Collectively, the accumulated molecular effects—trophoblastic dysfunction, impaired angiogenesis, mitochondrial damage, and HIF-1α feedback—explain the clinical phenomena observed: hypoxia, chronic inflammation, and endothelial dysfunction [101]. This evidence concerns the gene HIF1A and endothelial dysfunction.